Treatment of choice for Kawasaki Disease
**Core Concept**
Kawasaki Disease is an acute febrile vasculitis of childhood, characterized by inflammation of the blood vessels, particularly the coronary arteries. The treatment of choice involves anti-inflammatory agents to reduce the risk of coronary artery complications and prevent long-term cardiac sequelae.
**Why the Correct Answer is Right**
The treatment of Kawasaki Disease involves the administration of intravenous immunoglobulin (IVIG) to reduce inflammation and prevent the formation of coronary artery aneurysms. IVIG works by modulating the immune response and inhibiting the production of pro-inflammatory cytokines. Additionally, aspirin is often used in conjunction with IVIG to reduce inflammation and prevent platelet aggregation.
**Why Each Wrong Option is Incorrect**
**Option A:** Corticosteroids are not the primary treatment for Kawasaki Disease, as they may not be as effective as IVIG in preventing coronary artery complications.
**Option B:** Antiplatelet agents, such as aspirin, are used to reduce inflammation and prevent platelet aggregation, but they are not the primary treatment for Kawasaki Disease.
**Option C:** Colchicine is not a standard treatment for Kawasaki Disease and has not been shown to be effective in preventing coronary artery complications.
**Clinical Pearl / High-Yield Fact**
Kawasaki Disease is a medical emergency that requires prompt recognition and treatment to prevent long-term cardiac sequelae. IVIG should be administered within 10 days of the onset of fever to be effective.
**Correct Answer: B. Aspirin**